362 related articles for article (PubMed ID: 32305359)
1. American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States.
Mahmoudjafari Z; Alexander M; Roddy J; Shaw R; Shigle TL; Timlin C; Culos K
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1043-1049. PubMed ID: 32305359
[TBL] [Abstract][Full Text] [Related]
2. Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices.
Ardura M; Hartley D; Dandoy C; Lehmann L; Jaglowski S; Auletta JJ;
Biol Blood Marrow Transplant; 2020 Jul; 26(7):e147-e160. PubMed ID: 32339662
[TBL] [Abstract][Full Text] [Related]
3. Review of current clinical management guidelines for COVID-19 with special reference to India.
Kumar R; Vinod KS; Mittal A; Adhikari SD; Gupta N
Drug Discov Ther; 2020; 14(4):171-176. PubMed ID: 32908072
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: Main therapeutic options.
Hachfi W; Ben Lasfar N
Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
[No Abstract] [Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Hospital Pharmacy in the multidisciplinary team of COVID inpatient units.
Gil-Navarro MV; Luque-Márquez R
Farm Hosp; 2020 Jun; 44(7):40-42. PubMed ID: 32533669
[TBL] [Abstract][Full Text] [Related]
7. The clinical impact of COVID-19 epidemic in the hematologic setting.
Finelli C; Parisi S
Adv Biol Regul; 2020 Aug; 77():100742. PubMed ID: 32773103
[TBL] [Abstract][Full Text] [Related]
8. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.
Ljungman P; Mikulska M; de la Camara R; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Murray J; Peffault de Latour R; Snowden JA; Yakoub-Agha I; Verhoeven B; Kröger N; Styczynski J;
Bone Marrow Transplant; 2020 Nov; 55(11):2071-2076. PubMed ID: 32404975
[TBL] [Abstract][Full Text] [Related]
9. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
10. Treatment of COVID-19: old tricks for new challenges.
Cunningham AC; Goh HP; Koh D
Crit Care; 2020 Mar; 24(1):91. PubMed ID: 32178711
[No Abstract] [Full Text] [Related]
11. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
13. Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department.
Brown C; Noble J; Coralic Z
West J Emerg Med; 2020 Mar; 21(3):510-513. PubMed ID: 32302280
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.
Abena PM; Decloedt EH; Bottieau E; Suleman F; Adejumo P; Sam-Agudu NA; Muyembe TamFum JJ; Seydi M; Eholie SP; Mills EJ; Kallay O; Zumla A; Nachega JB
Am J Trop Med Hyg; 2020 Jun; 102(6):1184-1188. PubMed ID: 32323646
[TBL] [Abstract][Full Text] [Related]
15. Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
Oldenburg CE; Doan T
Am J Trop Med Hyg; 2020 Jun; 102(6):1154-1155. PubMed ID: 32297590
[No Abstract] [Full Text] [Related]
16. Hospital Pharmacist experience in the Intensive Care Unit: Plan COVID.
García-Gil M; Velayos-Amo C
Farm Hosp; 2020 Jun; 44(7):32-35. PubMed ID: 32533667
[TBL] [Abstract][Full Text] [Related]
17. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
[TBL] [Abstract][Full Text] [Related]
18. Physician drug prescribing preferences and availability for ventilation of patients with COVID-19.
Coombes ID; Dooley MJ; Townsend S; Carmichael S; Poole SG; Karamujic N; Richards B; Ziegenfuss M; Ankravs MJ; Uren H; Roberts JA; Holley A
Crit Care Resusc; 2020 Sep; 22(3):271-274. PubMed ID: 32900335
[No Abstract] [Full Text] [Related]
19. Pharmaceutical care in hospitalized patients. (Management of the COVID-19 pandemic crisis. A new challenge for pharmacy services).
Sevilla-Sánchez D; Tuset-Creus M
Farm Hosp; 2020 Jun; 44(7):28-31. PubMed ID: 32533666
[TBL] [Abstract][Full Text] [Related]
20. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
